HK1179248A1 - Novel spiroheterocyclic compounds as mglu5 antagonists - Google Patents
Novel spiroheterocyclic compounds as mglu5 antagonistsInfo
- Publication number
- HK1179248A1 HK1179248A1 HK13106089.4A HK13106089A HK1179248A1 HK 1179248 A1 HK1179248 A1 HK 1179248A1 HK 13106089 A HK13106089 A HK 13106089A HK 1179248 A1 HK1179248 A1 HK 1179248A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- mglu5 antagonists
- spiroheterocyclic compounds
- novel
- novel spiroheterocyclic
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36294410P | 2010-07-09 | 2010-07-09 | |
| PCT/EP2011/061690 WO2012004400A1 (en) | 2010-07-09 | 2011-07-08 | Novel spiroheterocyclic compounds as mglu5 antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1179248A1 true HK1179248A1 (en) | 2013-09-27 |
Family
ID=44503767
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK13106089.4A HK1179248A1 (en) | 2010-07-09 | 2013-05-23 | Novel spiroheterocyclic compounds as mglu5 antagonists |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US8580962B2 (pt) |
| EP (1) | EP2590985B1 (pt) |
| JP (1) | JP2013529673A (pt) |
| KR (1) | KR101862626B1 (pt) |
| CN (1) | CN103097391B (pt) |
| AU (1) | AU2011275696B2 (pt) |
| BR (1) | BR112013000529B1 (pt) |
| CA (1) | CA2800930C (pt) |
| EA (1) | EA023020B1 (pt) |
| ES (1) | ES2492694T3 (pt) |
| HK (1) | HK1179248A1 (pt) |
| IL (1) | IL223330A (pt) |
| MX (1) | MX2013000300A (pt) |
| NZ (1) | NZ603868A (pt) |
| SG (1) | SG186107A1 (pt) |
| UA (1) | UA110343C2 (pt) |
| WO (1) | WO2012004400A1 (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA113223C2 (xx) * | 2012-08-13 | 2016-12-26 | Арилетинілпіримідини | |
| JP6691127B2 (ja) * | 2014-12-29 | 2020-04-28 | レコルダーティ アイルランド リミテッドＲｅｃｏｒｄａｔｉ Ｉｒｅｌａｎｄ Ｌｉｍｉｔｅｄ | ヘテロシクリルアルキン誘導体およびそれらのｍＧｌｕＲ５受容体のモジュレーターとしての使用 |
| AU2016273751B2 (en) | 2015-06-03 | 2020-04-02 | F. Hoffmann-La Roche Ag | Ethynyl derivatives |
| CN107903265A (zh) * | 2017-11-21 | 2018-04-13 | 毛琳琳 | 一种新型螺环类杀虫剂的制备方法及应用 |
| CN116351472A (zh) * | 2023-02-22 | 2023-06-30 | 万华化学集团股份有限公司 | 一种催化精馏生产异氰酸酯的制备方法和系统 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW593241B (en) | 1999-04-20 | 2004-06-21 | Hoffmann La Roche | Carbamic acid derivatives |
| US6548522B1 (en) * | 1999-10-12 | 2003-04-15 | Hoffmann-La Roche Inc. | Method for treating conditions related to the glutamate receptor using carboxylic acid amide derivatives |
| AU1071301A (en) | 1999-11-01 | 2001-05-14 | Eli Lilly And Company | Pharmaceutical compounds |
| PT1294358E (pt) | 2000-06-28 | 2004-12-31 | Smithkline Beecham Plc | Processo de moagem por via humida |
| US6369222B1 (en) | 2000-07-18 | 2002-04-09 | Hoffmann-La Roche Inc. | mGluR antagonists and a method for their synthesis |
| GB0322612D0 (en) * | 2003-09-26 | 2003-10-29 | Novartis Ag | Organic compounds |
| GB0508318D0 (en) * | 2005-04-25 | 2005-06-01 | Novartis Ag | Organic compounds |
| DE102005044813A1 (de) | 2005-05-19 | 2007-10-04 | Grünenthal GmbH | Substituierte Spiro-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln |
| EP2061775A2 (en) * | 2006-09-13 | 2009-05-27 | Astra Zeneca AB | Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators |
-
2011
- 2011-07-08 WO PCT/EP2011/061690 patent/WO2012004400A1/en active Application Filing
- 2011-07-08 MX MX2013000300A patent/MX2013000300A/es active IP Right Grant
- 2011-07-08 CA CA2800930A patent/CA2800930C/en not_active Expired - Fee Related
- 2011-07-08 SG SG2012087912A patent/SG186107A1/en unknown
- 2011-07-08 EP EP11746494.1A patent/EP2590985B1/en active Active
- 2011-07-08 EA EA201270799A patent/EA023020B1/ru not_active IP Right Cessation
- 2011-07-08 JP JP2013517409A patent/JP2013529673A/ja not_active Withdrawn
- 2011-07-08 CN CN201180043746.5A patent/CN103097391B/zh not_active Expired - Fee Related
- 2011-07-08 BR BR112013000529-7A patent/BR112013000529B1/pt not_active IP Right Cessation
- 2011-07-08 ES ES11746494.1T patent/ES2492694T3/es active Active
- 2011-07-08 NZ NZ603868A patent/NZ603868A/en not_active IP Right Cessation
- 2011-07-08 KR KR1020137003488A patent/KR101862626B1/ko active IP Right Grant
- 2011-07-08 AU AU2011275696A patent/AU2011275696B2/en not_active Ceased
- 2011-07-11 US US13/180,166 patent/US8580962B2/en not_active Expired - Fee Related
- 2011-08-07 UA UAA201301071A patent/UA110343C2/ru unknown
-
2012
- 2012-11-28 IL IL223330A patent/IL223330A/en active IP Right Grant
-
2013
- 2013-05-23 HK HK13106089.4A patent/HK1179248A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| KR101862626B1 (ko) | 2018-05-31 |
| IL223330A0 (en) | 2013-02-03 |
| US20120059015A1 (en) | 2012-03-08 |
| NZ603868A (en) | 2014-08-29 |
| WO2012004400A1 (en) | 2012-01-12 |
| BR112013000529B1 (pt) | 2019-11-19 |
| ES2492694T3 (es) | 2014-09-10 |
| EA201270799A1 (ru) | 2013-05-30 |
| AU2011275696A1 (en) | 2012-12-20 |
| SG186107A1 (en) | 2013-01-30 |
| KR20130097153A (ko) | 2013-09-02 |
| EP2590985B1 (en) | 2014-05-14 |
| EA023020B1 (ru) | 2016-04-29 |
| AU2011275696B2 (en) | 2016-02-11 |
| IL223330A (en) | 2015-09-24 |
| MX2013000300A (es) | 2013-02-27 |
| CA2800930C (en) | 2018-08-21 |
| CN103097391B (zh) | 2015-04-08 |
| UA110343C2 (en) | 2015-12-25 |
| CA2800930A1 (en) | 2012-01-12 |
| JP2013529673A (ja) | 2013-07-22 |
| BR112013000529A2 (pt) | 2016-05-24 |
| CN103097391A (zh) | 2013-05-08 |
| US8580962B2 (en) | 2013-11-12 |
| EP2590985A1 (en) | 2013-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP3391A (en) | 2-Amino-4-arylthiazole compounds as TROA1 antagonists | |
| EP2627178A4 (en) | QUINAZOLINONE-LIKE COMPOUNDS AS CRTH2 ANTAGONISTS | |
| GB201005589D0 (en) | Novel compounds | |
| GB201007203D0 (en) | Novel compounds | |
| GB201012686D0 (en) | Novel compounds | |
| HK1179248A1 (en) | Novel spiroheterocyclic compounds as mglu5 antagonists | |
| GB201007791D0 (en) | Novel compounds | |
| GB201005811D0 (en) | Novel compounds A3 | |
| GB201019576D0 (en) | Novel compounds | |
| GB201019547D0 (en) | Novel compounds | |
| GB201019575D0 (en) | Novel compounds | |
| GB201019480D0 (en) | Novel compounds | |
| GB201014230D0 (en) | Novel compounds | |
| GB201014231D0 (en) | Novel compounds | |
| GB201014232D0 (en) | Novel compounds | |
| GB201012924D0 (en) | Novel compounds | |
| GB201012922D0 (en) | Novel compounds | |
| GB201010512D0 (en) | Novel compounds | |
| GB201010516D0 (en) | Novel compounds | |
| GB201010514D0 (en) | Novel compounds | |
| GB201010513D0 (en) | Novel compounds | |
| GB201010511D0 (en) | Novel compounds | |
| GB201010506D0 (en) | Novel compounds | |
| GB201010508D0 (en) | Novel compounds | |
| GB201010509D0 (en) | Novel compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20210710 |